Skip to content

Screener

Eligibility screening

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder

Sponsored by Jennifer AmengualStudy detailsClinicalTrials.gov

2 US sites in CA, NY

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.